https://www.lewrockwell.com/2024/10/no_author/three-ways-the-next-president-should-tackle-big-pharma/

By Amy Kelly and Naomi Wolf
Outspoken with Dr Naomi Wolf

October 25, 2024

Soon, we will either have elected the first female US President; or we will have re-elected a man written off by the Establishment. If the latter, this President will re-enter the White House with lawyer and Big Pharma critic Robert F. Kennedy, Jr. overseeing the Transition. We have learned that the checks and balances we had assumed ensure that only safe drugs get approved, do not exist.

From readers of RFK, Jr.’s bestseller The Real Anthony Fauci, which exposed royalties enriching government employees who align with pharma companies, to the parents declining HPV vaccines for their kids for safety reasons, to New Yorkers surprised that Bill di Blasio urged them to get COVID vaccines alongside free French fries, to those aware that our tax dollars pay for weight loss drug Ozempic — Americans don’t have to be “anti-vaxxers” to feel that Big Pharma reform is needed.

What actions can a new President take to ensure this?

1/ Repeal the PREP Act.

Some legislation seems great at first but proves to be destructive, such as the 2005 PREP (Public Readiness and Emergency Preparedness) Act.

This Act lets HHS provide immunity to drug companies from liability.

Thus, pharmaceutical “countermeasures” – some drugs — are not like automobiles, trampolines, or McDonald’s hot coffee. You cannot sue the manufacturer.

HHS designated the “free French fries” COVID-19 vaccines as “medical countermeasures.”

To extend the injection’s protections, HHS Secretary Becerra amended the PREP Act during COVID.

While that was happening, thousands of people sustained COVID vaccine injuries, even as our health agencies assured us that they were “safe and effective.”

To this day, the injured can’t sue. Imagine a PREP Act equivalent for the automobile industry. If a car malfunctioned, injuring you or killing a loved one, you would have nowhere to turn.

The PREP Act gives paltry options to those who do get hurt: the Countermeasures Injury Compensation Program.

As of October 1, 2024, only 17 COVID-19 vaccine injury compensations have been paid out under this program – totaling only $437,704.95.

Is the program adequate? Far from it.

“The CICP appears to be grossly underfunded according to the Health Resources and Services Administration (HRSA) operating plan […].”

Essentially, the compensation program is set up to fail Big Pharma victims.

It must go.

2/ The next President must campaign to repeal the National Childhood Vaccine Injury Act of 1986.

President Ronald Reagan signed the National Childhood Vaccine Injury Act of 1986 into law. NCVIA promotes arbitration, rather than litigation, for vaccine injury claims, thus protecting vaccine manufacturers from financial liability. It established the National Vaccine Injury Compensation Program, which created a Pharma-friendly no-fault Federal system for compensating vaccine-related injuries or deaths via the Court of Federal Claims and “special masters.”

The VICP also needs a complete overhaul to better help those seeking compensation for injuries. Since 1988, over 27,808 petitions have been filed. Only 11,315 were “compensable” while 12,840 were dismissed.

This program is failing those claiming injury from pharmaceutical products.

3. The next President must close the revolving door between Big Pharma and government agencies.

“Revolving door” is a cliché, but it is a useful one.

End snip - more on link above ^